About the webinar
Pharmacists discussed how to appropriately manage your patients with chronic liver disease, what medicines they should avoid, ways to ensure that their liver disease is appropriately monitored and when to refer for specialist management. This webinar was recorded in April 2023.
This recording was part of our primary care ‘on the couch’ discussions series. Each focussed on a different topic and featured discussions between subject matter experts. Recorded between 2023 and 2025, the resources aim to support you in your daily practice and can be watched on their own or as a series. Use the links at the top of the page to navigate between the different webinar recordings.
Why is it important
The incidence of chronic liver disease is increasing.
It is important that pharmacy professionals in primary care know how to appropriately manage these patients and advise them with regards their medications.
What you will learn
At the end of this “on the couch” conversation you should:
- appreciate that the incidence of liver disease is increasing and some of the reasons why
- list some of the complications of chronic liver disease and the medicines used to treat them
- summarise which medicines to avoid in chronic liver disease
- outline when to refer patients with liver disease for specialist management
Speakers
Non-SPS Speakers
Helen Boothman
Lead Hepatology Pharmacist, St George’s Hospital, London and Chair of the British Hepatology Pharmacy Group
Poonam Jethwa
Specialist Pharmacist, Wandle PCN, London
Kieran Reynolds
CPhO Clinical Fellow 2022-23, Specialist Pharmacy Service (SPS)
SPS Speakers
Learn more about the SPS team that facilitated this event below.
Recording
This webinar was recorded in April 2023. Information presented during this webinar is correct at time of recording. Current guidance should be followed.
Update history
- Republished
- Article reformatted and linked to primary care discussion webinar series
- Video format updated
- Title, summary and URL updated.
- Published